U.S.-based Sandoz, the generic pharmaceuticals division of Novartis, is recalling 270,000 bottles of hypertension tablets, manufactured by Hyderabad-based Mylan Laboratories, from the American market.
The recall involves bottles of Candesartan Cilexetil tablets that failed to meet impurities/degradation specifications and 9-month stability time point.
Candesartan Cilexetil is a generic verison of AstraZeneca's blood pressure drug Atacand.
In November 2015, Sandoz recalled the same drug manufactured from the same Mylan facility, for similar reasons.
Read the ET article
